Yahoo
    LSE - Delayed Quote USD

    Azenta, Inc. (0HQ1.L)

    38.46 -2.82 (-6.83%)
    At close: October 30 at 6:35:18 PM GMT
    Loading Chart for 0HQ1.L
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Azenta Stock Outlook After DNA Technology Deal

    Azenta Stock Outlook After DNA Technology Deal
    Simply Wall St. 3h ago
    3 small-cap stocks we find risky

    3 small-cap stocks we find risky
    StockStory 1d ago
    Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities

    Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities
    PR Newswire 2d ago
    Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast

    Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast
    PR Newswire 3d ago
    Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know

    Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
    StockStory 12d ago
    Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative

    Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative
    Simply Wall St. 14d ago
    Azenta (AZTA) Stock Could Be Undervalued Even With Legal Scrutiny

    Azenta (AZTA) Stock Could Be Undervalued Even With Legal Scrutiny
    Simply Wall St. 14d ago
    Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know

    Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
    StockStory 15d ago
    2 Volatile Stocks with Promising Prospects and 1 We Ignore

    2 Volatile Stocks with Promising Prospects and 1 We Ignore
    StockStory 17d ago
    Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)

    Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)
    StockStory 1mo ago
    Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems

    Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
    PR Newswire 1mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: